Abstract
The leading cause of death in humans has long been considered cancer. People have developed a variety of cancer treatments as science has advanced. However, the side effects and flaws of the therapies are still intolerable for patients. Cancer immunotherapy, which potentially can give a long-lasting treatment with minimal toxicities, finally appeared to address the inadequacies. Cancer immunotherapy keeps up with the advancements in contemporary health. In recent years, there have been many updates on the many subtypes of cancer immunotherapy. A brief history of cancer immunotherapy and the most current developments are summarized in this paper. The assessment also emphasizes the newest investment trend in cancer immunotherapy and prospective drug combinations.
Publisher
Darcy & Roy Press Co. Ltd.